CUSTOMIZE WITH SHOGUN
Skip to Main Content

julio 20, 2023

__biSgid://shopify/OnlineStoreArticle/562795675832_key_title__biiTobii Dynavox Interim report for second quater 2023__biE

__biSgid://shopify/OnlineStoreArticle/562795675832_key_body_html__bii

Tobii Dynavox AB (publ) today announced its results for the second quarter of 2023. 

Comments by Tobii Dynavox CEO Fredrik Ruben:

Our underlying growth continues with undiminished momentum despite facing a tougher comparison quarter from last year's Q2. We see strong momentum in the business across the board, including outside the US. At the same time, profitability continues to strengthen, driven by volume effects, gradually higher reimbursement levels in the insurance systems, and the fact that the pandemic no longer negatively impacts gross margin. We see a clear trend where growth is fastest in markets where we sell directly, boding well for the future. The acquisition of our German supplier Rehadapt has full potential to add profitable growth from day one. We remain optimistic about both growth and profitability going forward and are therefore investing in competencies, systems and tools to further increase scalability.

QUARTER APRIL – JUNE 2023

  • Revenue grew 32% to SEK 381 million (288). The currency adjusted growth was 24%.
  • Gross margin was 68% (64). 
  • Operating profit totaled SEK 29 million (16), corresponding to an operating margin of 7.6% (5.4). The operating margin was 9.2%, excluding non-recurring costs of SEK 6 million.
  • Cash flow after continuous investments was SEK 30 million (-30).
  • Basic and diluted earnings per share were SEK 0.16 (0.05). 

PERIOD JANUARY – JUNE 2023

  • Revenue grew 34% to SEK 716 million (535). The currency adjusted growth was 24%. 
  • Gross margin was 67% (64). 
  • Operating profit totaled SEK 50 million (33), corresponding to an operating margin of 7.0% (6.1). The operating margin was 7.8%, excluding non-recurring costs of SEK 6 million.
  • Cash flow after continuous investments was SEK 47 million (-58).
  • Basic and diluted earnings per share were SEK 0.23 (0.15).

SIGNIFICANT EVENTS DURING THE QUARTER

SIGNIFICANT EVENTS AFTER THE END OF THE QUARTER

COMMENTS FROM THE CEO 

Our underlying growth continues with undiminished momentum despite facing a tougher comparison quarter from last year's Q2. We see strong momentum in the business across the board, including outside the US. At the same time, profitability continues to strengthen, driven by volume effects, gradually higher reimbursement levels in the insurance systems, and the fact that the pandemic no longer negatively impacts gross margin. We see a clear trend where growth is fastest in markets where we sell directly, boding well for the future. The acquisition of our German supplier Rehadapt has full potential to add profitable growth from day one. We remain optimistic about both growth and profitability going forward and are therefore investing in competencies, systems and tools to further increase scalability.

Sales growth, denominated in local currency, was well above our long-term target at 24 percent. Growth was robust across all product and user groups. US Medicare's increase in the reimbursement level for our products by more than 9 percent will gradually affect revenues in 2023. Our income statement now reflects almost half of these price adjustments. As before, we expect to see the full impact by the end of the second half of the year.

Gross margin increased by 4 percentage points to 68 percent. The main reasons were the normalization of component and freight costs, as well as progressively higher sales prices.

Clearly, the distinct break in the trend toward increased sales growth that we saw just over a year ago was not temporary in nature. Our own large scale investments to educate prescribers and improve our products, along with constantly improving reimbursement systems in many countries, are producing clear results.

Our direct markets, including the recently added Irish and Danish markets, show the strongest growth. The main reason is that we have a much greater ability to effectively educate and support prescribers while gaining a deeper understanding of local requirements, processes and reimbursement systems. Educating the market about the potential of our products is key and critical for us to deliver on our major growth and profitability opportunities.

Our customer offering is highly competitive, and it is gratifying that our recently launched software titles have drawn so much attention. We can see rapid growth in their use. TD Browse, a browser specifically designed for users who control their device with eye movements, has also been nominated for several prominent awards. We continue to invest in development to gradually strengthen our product offering. New hardware, TD I-13 and TD I-16, was launched during the quarter, thereby upgrading our leading eye-tracking communication aids in the premium segment to the next level.

The acquisition of our long-standing German supply partner Rehadapt, which we agreed on at the end of June, naturally complements our offering while also strengthening our position in Germany. The com-pany offers medically certified “mounts,” a product that either we or our distributors combine with assis-tive communication devices when fixed, for example, to the user’s bed or wheelchair. The acquisition allows us to create solutions that make it easier for our users to access and use their assistive technology for communication. Rehadapt will be an independent subsidiary within the Group. We expect to close the deal in the third quarter, welcoming around 50 new colleagues.

Fredrik Ruben, CEO 

Webcast 

Today at 09:00 a.m. CET, Tobii Dynavox will host a webcast presentation for media, analysts and investors. 

If you want to attend the webcast click the following link

The interim report and a recording of the webcast will be available here

This information is inside information that Tobii Dynavox AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out below, at 07.30 CET on July 20th, 2023. 

__biE

Contact

__biSgid://shopify/OnlineStoreTheme/124153200824_key_section.article-financial-reports-template.PR_and_Communications_Manager_text__bii

Linda Tybring
CFO

linda.tybring@dynavoxgroup.com
+ 46 (0)706 81 49 80

__biE

About

__biSgid://shopify/OnlineStoreTheme/124153200824_key_section.article-financial-reports-template.about_text__bii

Dynavox Group AB (publ) is the parent company for Tobii Dynavox, the global leader in assistive communication. Headquartered in Stockholm, and listed on Nasdaq Stockholm (DYVOX), Dynavox Group, together with its brands has over 700 employees and serves customers in 65+ countries. Tobii Dynavox’s custom designed solutions enable people with disabilities such as cerebral palsy, ALS, autism and spinal cord injury to communicate with a voice of their own, develop literacy skills and live more independently. To date, hundreds of thousands of people worldwide have benefited from our integrated solutions, which include hardware, software, clinically developed language systems, mounting solutions, training, and dedicated support. We offer extensive funding expertise to facilitate funding for as many people as possible. As voice and motor impairments are common among our users, our solutions are accessed via alternative methods, such as eye gaze or touch screen. Using AI-based speech synthesis, we offer users a personalized voice identity in over 30 languages, for children and adults. 

__biE